Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
2995341000168111 | Scandonest (mepivacaine hydrochloride 66 mg / 2.2 mL) injection, 50 x 2.2 mL cartridges (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
2995351000168113 | Scandonest 3% (66 mg/2.2 mL) injection, 50 x 2.2 mL cartridges | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Scandonest 3% (66 mg/2.2 mL) injection, 50 x 2.2 mL cartridges | Is a | trade product pack | true | Inferred relationship | Some | ||
Scandonest 3% (66 mg/2.2 mL) injection, 50 x 2.2 mL cartridges | Is a | mepivacaine hydrochloride 3% (66 mg/2.2 mL) injection, 50 x 2.2 mL cartridges | true | Inferred relationship | Some | ||
Scandonest 3% (66 mg/2.2 mL) injection, 50 x 2.2 mL cartridges | has TPUU | Scandonest 3% (66 mg/2.2 mL) injection, 2.2 mL cartridge | true | Inferred relationship | Some | 1 | |
Scandonest 3% (66 mg/2.2 mL) injection, 50 x 2.2 mL cartridges | has TP | Scandonest | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Scandonest 3% (66 mg/2.2 mL) injection, 50 x 2.2 mL cartridges | Is a | True | Scandonest 3% (66 mg/2.2 mL) injection, 50 x 2.2 mL cartridges | Inferred relationship | Some |
Reference Sets
Trade product pack reference set